UK markets close in 5 hours 11 minutes

Mereo BioPharma Group plc (MREO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.0500+0.2900 (+10.51%)
At close: 04:00PM EDT
3.0500 0.00 (0.00%)
After hours: 06:48PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
7,128
10,000
0
49,213
0
Cost of revenue
1,871
2,574
-1,146
24,169
0
Gross profit
5,257
7,426
1,146
25,044
0
Operating expenses
Research development
19,538
17,418
29,465
31,796
22,278
Selling general and administrative
20,251
18,424
26,107
21,504
28,922
Total operating expenses
39,789
34,562
53,844
53,300
51,200
Operating income or loss
-34,532
-27,136
-52,698
-28,256
-51,200
Interest expense
2,955
2,881
4,175
5,400
8,699
Total other income/expenses net
5,540
-2,112
13,095
52,903
-167,003
Income before tax
-28,137
-29,998
-42,938
19,220
-226,842
Income tax expense
-2,069
-532
-718
2,046
-3,846
Income from continuing operations
-26,068
-29,466
-42,220
17,174
-222,996
Net income
-26,068
-29,466
-42,220
17,174
-222,996
Net income available to common shareholders
-26,068
-29,466
-42,220
17,174
-222,996
Basic EPS
-0.25
-
-0.36
0.13
-3.27
Diluted EPS
-0.25
-
-0.36
-0.34
-3.27
Basic average shares
124,959
-
113,987
105,564
68,178
Diluted average shares
124,959
-
113,987
111,055
68,178